Anti-microbial Perspective of a Chalcone, (E)-1-(1-methoxy-9H-carbazol-3-yl)-3-(4-(methylsulfonyl) phenyl)prop-2-en-1-one: Fabrication of a Hybrid by Unification of a Natural Product with a Synthetic Component
Keywords:
Murraya koenigii, murrayanine, chalcone, methylsulfonyl, antimicrobial, antibacterialAbstract
Murraya koenigii L. has been explored exhaustively and is known to possess more than 20 different carbazole-based alkaloids having multifarious therapeutic perception of this class of alkaloids, murrayanine is the highest explored alkaloid and is known to have (ethno)-pharmacological perspectives of purgative, astringent, febrifuge, anti-helminthic, anti-oxidant, anti-ulcerogenic, immunomodulation, etc. As murrayanine possess multiple sites for substituting wide-range of electron-donating / -withdrawing groups by semi-synthetic approach, in the present research, a chalcone; (E)-1-(1-methoxy-9H-carbazol-3-yl)-3-(4-(methylsulfonyl)phenyl)prop-2-en-1-one was fabricated rationally by incorporating a natural portion (murrayanine) in the A-ring and a synthetic component (4-methylsulfonyl group) in the B-ring and screened against two bacterial species (Escherichia coli and Staphylococcus aureus) and two fungal species (Candida albicans and Aspergillus niger). The rationally designed chalcone demonstrated noteworthy anti-microbial activity. The fabricated chalcone was observed to be a better anti-bacterial agent as compared to its anti-fungal potentials. As compared to the standard drugs, the experimental molecule does hold well against pathogenic challenges. The present research therefore opened new avenues of judiciously developing a natural scaffold having an active methylsulfonyl group, which will inspire life science researchers across the globe in developing inhibitors with pronounced biological activity as compared with the parent compounds.
References
Guda DR, Park SJ, Lee MW, Kim TJ, Lee ME. Syntheses and anti-allergic activity of 2-((bis (trimethylsilyl) methylthio/methylsulfonyl) methyl)-5-aryl-1, 3, 4-oxadiazoles. Eur J Med Chem 2013;62:84-8.
Ismail B, Ghezali L, Gueye R, Limami Y, Pouget C, Leger DY, Martin F, Beneytout JL, Duroux JL, Diab-Assaf M, Fagnere C. Novel methylsulfonyl chalcones as potential antiproliferative drugs for human prostate cancer: Involvement of the intrinsic pathway of apoptosis. Int J Oncol 2013;43(4):1160-8.
Kamble MA, Mahapatra DK, Dhabarde DM, Ingole AR. Pharmacognostic and pharmacological studies of Bombax ceiba thorn extract. J Pharm Pharmacog Res 2017;5(1):40-54.
Kamble VM, Hatnapure GD, Keche AP, Biradjar S, Patil SG, Tale RH, Rodge AH, Turkar SS, Gour K. Synthesis and Biological Evaluation of a Novel Series of Methoxylatedchalcone as Antioxidant and Anti-microbial Agents. J Chem Pharm Res 2011;3(6):639-48.
Lad NP, Manohar Y, Mascarenhas M, Pandit YB, Kulkarni MR, Sharma R, Salkar K, Suthar A, Pandit SS. Methylsulfonyl benzothiazoles (MSBT) derivatives: Search for new potential antimicrobial and anticancer agents. Bioorg Med Chem Lett 2017;27(5):1319-24.
Lim H, Kim HJ, Jeong H, Park HR. Anti-inflammatory effects of 1-isothiocyanato-7-(methylsulfonyl) heptane by suppressing the NFκ-B signaling pathway. Eur J Inflam 2017;15(2):57-65.
Mahapatra DK, Das D, Shivhare RS, Borkar SS. Murrayanine-hydantoin and -thiohydantoin analogs as promising anti-convulsant agents: Synthesis, Characterization and Molecular Docking Studies. MOJ Bioorg Org Chem 2018;2(2):47-51.
Mahapatra DK, Shivhare RS, Gupta SD. Anxiolytic activity of some 2,3-dihydrobenzo[b][1,4]oxazepine derivatives synthesized from Murrayanine-Chalcone. Asian J Res Pharm Sci 2018a;8(1):25-29.
Mahapatra DK, Shivhare RS, Asati V. Locomotor inhibitory activity of some Murrayanine-Chalcone based 2,3-dihydrobenzo[b][1,4]thiazepine derivatives: Exploring Anxiolytic potentials. Chronicle Pharm Sci 2018b;2(1):462-468.
Mahapatra DK, Shivhare RS, Ugale VG. Anti-inflammatory potentials of some novel Murrayanine containing 1,3,4-Oxadiazole derivatives. Asian J Pharm Technol 2018c;8(1):47-51.
Mahapatra DK, Shivhare RS, Kumar P. Murrayanine-chalcone transformed into novel pyrimidine compounds demonstrated promising anti-inflammatory activity. Asian J Pharm Res 2018d;8(1):6-10.
Mahapatra DK, Bharti SK, Eds. Handbook of Research on Medicinal Chemistry. New Jersey: Apple Academic Press, 2017.
Mahapatra DK, Shivhare RS, Joseph TM. Design and characterization of Murrayanine linked Isoxazole derivatives: Novel class of bacteriocidal agents. Int J Res Drugs Pharm Sci 2017;1(1):11-15.
Mahapatra DK, Shivhare RS, Bharti SK. Novel Murrayanine based Pyrazole analogs as emerging anti-fungal candidates: Design, synthesis, characterization, and in vitro evaluation. Res Pharm 2017a; 1(1): 1-5.
Mahapatra DK, Shivhare RS. Synthesizing an anti-oxidant principle 2-(((1-methoxy-9H-carbazol-3-yl)methylene)amino)isoindoline-1,3-dione from N-aminophthalimide and murrayanine. Inventi Med Chem 2017b;2017(4):1-3.
Mahapatra DK, Shivhare RS, Haldar AGM. Novel Schiff’s base containing Murrayanine–1,3,4-Thiadiazole Hybrids as potential anti-inflammatory agents. Asian J Chem Pharm Sci 2017c;2(2):10-15.
Mahapatra DK, Das D, Shivhare RS. Substituted thiazole linked murrayanine-Schiff’s base derivatives as potential anti-breast cancer candidates: Future EGFR Kinase inhibitors. In J Pharm Sci Drug Res 2017d;9(3):139-144.
Mahapatra DK, Chhajed SS, Shivhare RS. Development of Murrayanine-Chalcone hybrids: An effort to combine two privilege scaffolds for enhancing hypoglycemic activity. Int J Pharm Chem Anal 2017e;4(2):30-34.
Mahapatra DK, Bharti SK, Asati V. Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives. Curr Top Med Chem 2017f;17(28):3146-69.
Mahapatra DK, Bharti SK, Asati V. Chalcone scaffolds as anti-infective agents: Structural and molecular target perspectives. Eur J Med Chem 2015;101:496-524.
Mahapatra DK, Bharti SK, Asati V. Anti-cancer chalcones: Structural and molecular target perspectives. Eur J Med Chem 2015a;98:69-114.
Mahapatra DK, Asati V, Bharti SK. Chalcones and their therapeutic targets for the management of diabetes: structural and pharmacological perspectives. Eur J Med Chem 2015b;92:839-65.
Shivhare RS, Mahapatra DK, Nair RR, Deshmukh SN. Schiff’s base derivatives of murrayanine demonstrated enhanced anti-oxidant activity than its parent moiety. Indian J Pharm Edu Res 2016;50(3):9-15.
Telrandhe R, Mahapatra DK, Kamble MA. Bombax ceiba thorn extract mediated synthesis of silver nanoparticles: Evaluation of anti – Staphylococcus aureus activity. Int J Pharm Drug Anal 2017;5(9):376-379.
Published
Issue
Section
License
Copyright (c) 2018 Author
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journals offer different licence options, please see the Instructions to Authors page of the relevant journal for more information.
Books and book chapters
When publishing a book, or a chapter in a book, the terms of licensing and copyright will typically be included in a contract which you would have to agree with a publisher and which will specify the usage rights, the format(s) and length of time applied to the work.
Book contracts vary from publisher to publisher, and can in some cases be complicated. If you are required to sign a contract with a publisher in order to publish your work you need to ensure that the contract covers your rights and that it takes into account the obligation you have to your employer and/or the funder of your research.
If you want to publish a thesis or dissertation it is recommended that you contact your institution or department to make sure that you follow their policy for such publications.
Kindly Check the concern book title for How To Cite. Plese ignore if any citation format provided in Book Section
